The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure
Journal
Acta Cardiologica Sinica
Journal Volume
38
Journal Issue
6
Pages
700-713
Date Issued
2022-11
Author(s)
Chiang, Chern-En
Kuo, Jen-Yuan
Yin, Wei-Hsian
Wen, Ming-Shien
Lo, Ping-Han
Liu, Ping-Yen
Lin, Tsung-Hsien
Chen, Zhih-Cherng
Shyu, Kou-Gi
Hung, Ming-Jui
Tseng, Chuen-Den
Abstract
Patients admitted with acute decompensated heart failure (ADHF) have a poor prognosis and poor quality of life due to dyspnea and edema. Tolvaptan, a vasopressin V2 receptor antagonist, is an effective water diuretic. This study aimed to evaluate the efficacy and safety of a short course of tolvaptan to treat volume overload in patients with ADHF.
Subjects
ADHF; Diuretic; Heart failure; Tolvaptan
SDGs
Publisher
TAIWAN SOC CARDIOLOGY
Type
journal article